✦ LIBER ✦

Phase II study of the CPT-11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B-cell lymphoma

✍ Scribed by Nozomi Niitsu; Mika Kohuri; Masaaki Higashihara; Masami Bessho

Book ID: 108583686
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 178 KB
Volume: 97
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2006.00249.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of the irinotecan (CPT-11

Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma

✍ Nozomi Niitsu; Mika Kohori; Masaaki Higashihara; Masami Bessho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Multicentre phase II study of CyclOBEAP

Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma

✍ Nozomi Niitsu; Mika Kohri; Yuki Hagiwara; Ken Tanae; Naoki Takahashi; Masami Bes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract The R‐CHOP regimen has been found to improve the outcome of diffuse large B‐cell lymphoma (DLBCL). However, it does not provide a satisfactory treatment outcome in the high‐risk group. We previously administered the CyclOBEAP regimen to patients with DLBCL, and reported its safety and e

Phase II study of oral fludarabine in co

Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma

✍ Kensei Tobinai; Ken-ichi Ishizawa; Michinori Ogura; Kuniaki Itoh; Yasuo Morishim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 955 KB

Phase II study of a salvage regimen usin

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Importance of maintaining the relative d

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

✍ Tsuneaki Hirakawa; Hiroki Yamaguchi; Norio Yokose; Seiji Gomi; Koiti Inokuchi; K 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 166 KB

A phase II study of a THP-COP regimen fo

A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma

✍ Hisashi Tsurumi; Takeshi Hara; Naoe Goto; Nobuhiro Kanemura; Senji Kasahara; Mic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract Pirarubicin (tetrahydropyranyl adriamycin: THP) is an anthracycline drug that reportedly has fewer cardiotoxic effects than doxorubicin. A phase II study was conducted in order to determine the efficacy of a treatment regimen incorporating THP, namely THP‐COP in the treatment of elderly